Bioventus (BVS) Acquisitions (2021 - 2022)
Bioventus' (BVS) quarterly Acquisitions came in at $104.6 million in Q4 2022, up 328.46% on a YoY basis from $24.4 million in Q4 2021, and up 2092300.0% quarter-over-quarter from -$5000.0 in Q3 2022.
Powered by 
Analysis
Bioventus (BVS) Acquisitions (2021 - 2022) Analysis & Trends
Bioventus (BVS) has reported Acquisitions for 2 consecutive years, with $104.6 million the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Acquisitions rose 328.46% year-over-year to $104.6 million; the trailing twelve-month figure through Oct 2022 stood at $367.7 million (changed N/A YoY), and the FY2021 full-year result was $262.9 million, changed N/A from the prior year.
- Acquisitions grew to $104.6 million in Q4 2022 per BVS's latest filing, from -$5000.0 in the prior quarter.
- Across five years, Acquisitions topped out at $262.9 million in Q4 2021 and bottomed at -$45.8 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.16 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 437.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Bioventus | 1.18 Bn | 1.20 Bn | 105.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 1, 2022 | 104.61 Mn |
| Jul 2, 2022 | -5,000.00 |
| Apr 2, 2022 | 236,000.00 |
| Dec 31, 2021 | 262.87 Mn |
| Oct 2, 2021 | -45.79 Mn |
| Jul 3, 2021 | -1,000.00 |
| Apr 3, 2021 | 45.79 Mn |